TrialCancer immunology, immunotherapy : CII2020

Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients.

H Daiko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.